On Sept. 12, 2013, OHSU announced it had launched a clinical and translational science initiative to turn the tables on pancreatic disease. With support from a landmark $25 million philanthropic pledge, a team of OHSUﾒs top pancreatic surgeons and Knight Cancer Institute scientists will co-develop new detection and treatment methods for pancreatic cancer while solving longstanding mysteries of pancreatic disease at the molecular level.